This is a promotional website intended for UK healthcare professionals (HCPs) only. Adverse event reporting and prescribing information can be found at the bottom of the page. This website is owned and funded by Bavarian Nordic.
You have no items in your basket.
Our Products
We have a strong heritage in vaccine development, and a firm focus on vaccines stands at the core of everything we do. Explore our portfolio of products currently available in the United Kingdom.
Rabipur® is indicated for active immunisation against rabies in individuals of all ages, before possible contact with the rabies virus (pre-exposure prophylaxis) or for the treatment of those who presumably or actually had contact with the rabies virus (post-exposure prophylaxis).1
The use of this vaccine should be in accordance with official recommendations.
Vimkunya® is indicated for active immunisation for the prevention of disease caused by chikungunya virus in individuals 12 years and older.2
Vivotif® is indicated for active oral immunisation against typhoid fever in adults and children aged 5 years and over.3
Vaxchora® is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older.4
IMVANEX® is currently supplied directly to the UK government for use in the mpox programme. IMVANEX® is indicated for active immunisation against smallpox, mpox and disease caused by vaccinia virus in adults.5
Published date: 1 May 2026
UK-CHIK-2600016 | May 2026
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ . Adverse events should also be reported to Bavarian Nordic: [email protected].
This site is intended for UK healthcare professionals only and contains information on Bavarian Nordic's medicines, educational materials, and more. Please click the appropriate button below to proceed.
By entering this site, you confirm that you are a UK healthcare professional. This site includes promotional content. Please be aware that some information may only be relevant to HCPs practicing in the UK.
UK-CHIK-2600005 | May 2026
Gain full access to all of our content by creating an account.